Glycopyrrolate/indacaterol (AeroRX Therapeutics/HCmed)

格隆溴铵/茚达特罗 (AeroRX Therapeutics/HCmed)

Report date: 2025/04/22 14:43:20

Base Information

Drug NameGlycopyrrolate/indacaterol (AeroRX Therapeutics/HCmed)
Drug Alias NameLABA/LAMALAMA/LABAIndacaterol/glycopyrrolateAERO-007AERO-001/AERO-002 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor antagonistsBeta adrenergic receptors agonists
TargetsMuscarinic acetylcholine receptorBeta adrenergic receptors
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsYes AERO-001AERO-002
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAeroRx Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAeroRx Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic Obstructive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A